We next investigated the effects of SPRY2 on growth under hormone deprivation in LNCaP cells, an AR‐proficient prostate cancer cell line deficient for both SPRY2 and PTEN (Fig EV1K). The gene discussed is PTEN; the disease is prostate cancer.